The enzyme analysis results of all these studies revealed that MMP2, MMP9, TIMP1, and TIMP2 were low and cathepsin K was high in MPS III patients, and that the patients had low bone density and increased osteoporosis risk. This evidence concerns the gene MMP9 and osteoporosis.